Correlation Between Infant Bacterial and Alligator Bioscience
Can any of the company-specific risk be diversified away by investing in both Infant Bacterial and Alligator Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Infant Bacterial and Alligator Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Infant Bacterial Therapeutics and Alligator Bioscience AB, you can compare the effects of market volatilities on Infant Bacterial and Alligator Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Infant Bacterial with a short position of Alligator Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Infant Bacterial and Alligator Bioscience.
Diversification Opportunities for Infant Bacterial and Alligator Bioscience
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Infant and Alligator is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Infant Bacterial Therapeutics and Alligator Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alligator Bioscience and Infant Bacterial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Infant Bacterial Therapeutics are associated (or correlated) with Alligator Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alligator Bioscience has no effect on the direction of Infant Bacterial i.e., Infant Bacterial and Alligator Bioscience go up and down completely randomly.
Pair Corralation between Infant Bacterial and Alligator Bioscience
Assuming the 90 days trading horizon Infant Bacterial is expected to generate 1.49 times less return on investment than Alligator Bioscience. But when comparing it to its historical volatility, Infant Bacterial Therapeutics is 1.9 times less risky than Alligator Bioscience. It trades about 0.05 of its potential returns per unit of risk. Alligator Bioscience AB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 527.00 in Alligator Bioscience AB on April 23, 2025 and sell it today you would earn a total of 25.00 from holding Alligator Bioscience AB or generate 4.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Infant Bacterial Therapeutics vs. Alligator Bioscience AB
Performance |
Timeline |
Infant Bacterial |
Alligator Bioscience |
Infant Bacterial and Alligator Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Infant Bacterial and Alligator Bioscience
The main advantage of trading using opposite Infant Bacterial and Alligator Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Infant Bacterial position performs unexpectedly, Alligator Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alligator Bioscience will offset losses from the drop in Alligator Bioscience's long position.Infant Bacterial vs. IGM BIOSCIENCES DL 01 | Infant Bacterial vs. Isofol Medical AB | Infant Bacterial vs. Alligator Bioscience AB | Infant Bacterial vs. Cantargia AB |
Alligator Bioscience vs. Cantargia AB | Alligator Bioscience vs. BioArctic AB | Alligator Bioscience vs. Oncopeptides AB | Alligator Bioscience vs. Hansa Biopharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |